Here is the synopsis of our sample research paper on Antibody Technology. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
This 3 page paper provides an overview of how monoclonal antibody technology works, how it has been applied to solve a particular problem and its strengths and weaknesses in relation to other technologies used to address this problem. Bibliography lists 6 sources.
Page Count:
3 pages (~225 words per page)
File: AM2_PP675996.doc
Buy This Term Paper »
Unformatted sample text from the term paper:
the human body when foreign antigens enter our system. Antibodies are blood proteins that act on a molecular level by binding with the antigens so that they can be
more easily removed from the system. Even after the initial attack from an outside entity has been effectively dealt with, the antibodies that were produced in response to that
attack remain in the body. They are there waiting in the background just in case we come in contact with that pathogen in its unaltered form again. The
natural production of antibodies, however, takes time. Individuals must independently develop them and, in the meantime, many succumb to disease. Fortunately, recent developments in antibody technology offer a
leg-up in fighting disease. Monoclonal antibody technology is particularly interesting in this regard. Monoclonal antibody technology works by isolating antibodies that have
been naturally produced to create what Ledford (2007, 437) refers to as "a library of immune proteins". This library is created using antibodies produced by individuals that are intentionally
inoculated (Ledford, 2007, 437). In one respect at least, are a sort of priming agent. That is they prepare the body to go into action in a quick
and efficient manner when a disease is encountered. They circumvent the need for immunity to be developed individual by individual. Because the body has had previous experience with
a particular type of pathogen there are already antibodies there waiting to react against the antigens of that pathogen. As TIC (2010) observes "Passive immunisation can be a powerful
treatment option against infectious diseases in sometimes life threatening situations". The antibodies that are produced by monoclonal antibody technology have thus
...